Who
Christine A. Pellizzari
Director
Company insider
Files Form 4 as: Director, Imunon; Director, Tempest Therapeutics; Chief Legal and HR Officer, Science 37 Holdings; Chief Legal Officer, Insmed; Sr VP, General Counsel & Secty, Dendrite International.
In numbers
- Trades disclosed
- 148
- Buys
- 5
- Sells
- 8
- Bought
- $412K
- Sold
- $7.9M
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 1 May 2006
- Last trade
- 31 Jul 2026
- Last filed
- 4 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Jul 2026filed 4 Aug 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $11K6,934 at $1.59 | filing |
| 31 Jul 2026filed 4 Aug 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $11K6,934 at $1.59 | filing |
| 22 May 2026filed 27 May 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $12K5,557 at $2.20 | filing |
| 22 May 2026filed 27 May 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $12K5,557 at $2.20 | filing |
| 27 Jan 2026filed 28 Jan 2026 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,230 at $0.00 | filing |
| 27 Jan 2026filed 28 Jan 2026 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,230 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | IMNN Imunonoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,827 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | IMNN Imunonoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,827 at $0.00 | filing |
| 4 Aug 2025filed 6 Aug 2025 | IMNN Imunonoption or derivative · Biotechnology | SEC FORM 4 Code A | —250 at $0.00 | filing |
| 4 Aug 2025filed 6 Aug 2025 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $21K2,248 at $9.20 | filing |
| 14 Mar 2025filed 18 Mar 2025 | IMNN Imunonoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,750 at $0.00 | filing |
| 6 Sep 2024filed 10 Sep 2024 | IMNN Imunonoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,964 at $0.00 | filing |
| 13 Jun 2024filed 14 Jun 2024 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 12 Jun 2024filed 14 Jun 2024 | IMNN Imunonoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,500 at $0.00 | filing |
| 15 Mar 2024filed 18 Mar 2024 | IMNN Imunonoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,500 at $0.00 | filing |
| 12 Mar 2024filed 12 Mar 2024 | Science 37 Holdingsoption or derivative | SEC FORM 4 Code D | —37,222 | filing |
| 12 Mar 2024filed 12 Mar 2024 | Science 37 Holdingsoption or derivative | SEC FORM 4 Code D | —428 | filing |
| 12 Mar 2024filed 12 Mar 2024 | Science 37 Holdings | SEC FORM 4 Code U | $84K14,579 at $5.75 | filing |
| 12 Mar 2024filed 12 Mar 2024 | Science 37 Holdings | SEC FORM 4 Code D | $202K35,115 at $5.75 | filing |
| 12 Aug 2023filed 15 Aug 2023 | Science 37 Holdingsoption or derivative | SEC FORM 4 Code M | —355,549 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.